SUPPLEMENTARY MATERIALS AND METHODS
Study Population: Patients for inclusion, at screening had confirmed radiological bronchiectasis by high resolution computed tomography (HRCT) scanning of the thorax. Patients were recruited during routine visits to the outpatient clinic and were clinically stable at recruitment. Clinical stability was defined as the absence of new symptoms and where no change to bronchiectasis therapy had occurred in the preceding six week period. Patients were excluded if they had any other major respiratory diagnosis (asthma or COPD) out-ruled by clinical symptoms and established spirometry criteria [1, 2] , were pregnant or breastfeeding, had active mycobacterial disease or were on chemotherapy for malignancy. Patients with any active infection (necessitating acute use of antibiotics) or taking systemic corticosteroids in the four weeks preceding recruitment were excluded. Ten nondiseased controls were recruited in Singapore and defined as never smokers with no active or past history of any respiratory or other medical disease with normal spirometry (Easy One© NDD Medical Technologies). A total of n=138 bronchiectasis patients were recruited to the Singapore/Kuala Lumpur (SG-KL) cohort, and n=100 'matched' individually by age, sex and total bronchiectasis severity index (BSI) score (assigned at time of sample acquisition) to patients in the Dundee (DD) cohort (total CAMEB study population, n=238). Patients known to have active ABPA (defined by established criteria) at enrolment were excluded [3] . Clinical data and specimen collection: Disease severity was assigned according to Bronchiectasis Severity Index (BSI) and further divided into 'Mild' (BSI; 0-4), 'Moderate' (BSI; 5-8) or 'Severe' (BSI; 9 and above) categories, which was the basis for disease severity matching in CAMEB [4] . Sputum and blood were obtained from each participant. Spontaneously expectorated 'representative' sputum from a deep cough with the assistance of a chest physiotherapist (where appropriate) was collected in sterile containers and transported (on ice) for evaluation [5] . An equal volume of Sputasol (Thermo Fisher Scientific) was added to each sample and shaken for 15 minutes at 37°C. Sputasol-homogenised samples were either stored (-80°C) or mixed with two volumes of RNAlater (Sigma-Aldrich) for DNA extraction and mycobiome analysis [6] . Blood specimens were collected in vacutainer serum tubes (BD biosciences) and centrifuged at 1300g for 10 minutes at 18°C to separate serum which was used for immunological studies. All CAMEB specimens from clinical sites were transported promptly, appropriately and processed centrally in Singapore to ensure consistency and standardisation of all experimental work. To ensure quality control of materials transported from sites outside Singapore, specimens were temperature controlled and their integrity checked on arrival to Singapore before experimental use. 
4).
Sputum DNA extraction: Sputum DNA was extracted using methods previously described [6] . Briefly, sputum samples in RNAlater were centrifuged at 13000rpm for 10 minutes and resultant pellets resuspended in 500µL sterile phosphate-buffered saline (PBS) (GE Lifesciences) and transferred to sterile bead mill tubes (VWR) containing 1mm sterile glass beads (Sigma-Aldrich). Next, homogenisation using a bead mill homogeniser (VWR) was performed and DNA purified using the Roche High-pure PCR Template Preparation Kit (Roche) according to manufacturers' instructions.
Mycobiome analysis

Construction of Shotgun Sequencing Libraries of Amplified Fungal Internal
Transcribed Spacer (ITS) Regions ITS1 and ITS2: The previously described flanking primer pair ITS1 and ITS4 was chosen amplify the ITS1-5.8S-ITS2 Internal Transcribed Spacer (ITS) regions (Table E1 ) [8] . To assess the ability of this primer pair to target the ITS region in diverse fungal taxa relevant to our investigations, the Polymerase Chain Reaction (PCR) efficiency of the primers was determined against different fungal species (Table E2) (Table E2 ).
For the preparation of amplicon shotgun sequencing libraries, purified sputum DNA served as a template for PCR using the ITS1/ITS4 primers. Each PCR reaction contained 50 ng of extracted DNA in a master mix containing the following components (Thermo Fisher Scientific); 2.5 µl of 10X buffer, 1.5 µl of 50 mM MgCl 2 , 0.14 µl of Platinum Taq DNA polymerase, 0.5 µl of 25mM dNTPs and 2.5 µl of each primer at a concentration of 1 µM. Reaction volumes were adjusted to 25 µl with molecular grade water. PCR conditions were as follows: denaturation at 94°C for 2min, followed by 35 cycles at 94°C for 30s, annealing at 57°C for 30s and extension at 72°C for 1min. Agencourt AMPure XP beads (Beckman Coulter) were used to purify amplicons using 1.5 times the volume of PCR product with final elution in 20 µl of EB buffer (Qiagen). Purified products were then visualised using Agilent Bioanalyser, prepared with an Agilent DNA1000 Kit (Agilent Technologies). PCR product was topped-up to 50µl and subjected to shearing using Adaptive Focused Acoustics TM (Covaris). Fragment size ranged from 150 -600 bp. DNA libraries were prepared by using the Gene Read DNA Library I Core Kit (Qiagen) according to manufacturers' instructions except for the use of a custom adaptor in place of GeneRead Adapter I Set (Table E1) . Fourteen cycles of enrichment PCR was carried out with index-primers according to a protocol adapted from the Multiplexing Sample Preparation Oligonucleotide kit (Illumina). Libraries were quantified using Agilent
Bioanalyser, prepared with Agilent DNA1000 kit (Agilent Technologies). Paired-end sequencing (2 x 101 bp reads) was performed on DNA libraries using the Illumina HiSeq2500 platform.
Bioinformatic methods: Raw sequence reads (3.29 +/-0.184 million reads per sample)
were quality trimmed using famas (v0.0.7) and analysed using a modified version of the pipeline described in Ong et al. Table E3 . qPCR assays with crossover thresholds (CT)
values of <40 for were considered positive. For quantification of sputum conidial burden, the 18S ITS1 region was amplified as described and cloned using the TAcloning system in the pGEM-T easy vector (Promega) in order to generate standard curves ranging from a 10 2 -10 6 gene copies, against which the conidial burden per gram of sputum for each sample was determined [6] . for 3s and annealing/extension at 60°C for 30s. Table E3 . Primers and probes for detection of specific Aspergillus species.
Immunological bioassays
Species Primers Probe
A. fumigatus Table E4 . Summary of the immunologic classification used to stratify patients by category of Aspergillosis including Non-diseased (ND);
Aspergillus-colonized (AC); Aspergillus-sensitized (AS); serological allergic bronchopulmonary aspergillosis (sABPA) and suspected chronic pulmonary aspergillosis (sCPA). These criteria have been modified from that published for use in cystic fibrosis by Baxter et al. [24] 
